STOCK TITAN

[Form 4] Tilray Brands, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Ventas, Inc. (VTR) – Form 144 filing: Robert F. Probst has filed notice to sell 3,900 common shares through Merrill Private Wealth on or about 31 Jul 2025. The shares were obtained the same day via a cash-less exercise of employee stock options. Estimated aggregate market value is $266,960. Ventas reports 454,471,192 shares outstanding, so the proposed sale equals roughly 0.0009% of the float.

The filer has already sold 288,875 shares of Ventas common stock during the past three months across five transactions, generating $18.86 million in gross proceeds. No adverse information about the issuer is asserted in the filing, and the filer certifies compliance with Rule 144 and, if applicable, Rule 10b5-1.

Key takeaways:

  • Small additional insider sale relative to shares outstanding.
  • Continued insider disposition trend (≈0.06 % of shares outstanding in prior 90 days).
  • Sale conducted via established broker; no mention of lock-ups or restrictions.

Ventas, Inc. (VTR) – Comunicazione Form 144: Robert F. Probst ha presentato una notifica per la vendita di 3.900 azioni ordinarie tramite Merrill Private Wealth intorno al 31 luglio 2025. Le azioni sono state ottenute lo stesso giorno mediante un esercizio senza esborso di opzioni azionarie per dipendenti. Il valore di mercato aggregato stimato è di 266.960 $. Ventas riporta 454.471.192 azioni in circolazione, quindi la vendita proposta rappresenta circa lo 0,0009% del flottante.

Il dichiarante ha già venduto 288.875 azioni ordinarie di Ventas negli ultimi tre mesi in cinque transazioni, generando 18,86 milioni di $ di ricavi lordi. Nel modulo non sono riportate informazioni negative sull’emittente e il dichiarante certifica il rispetto della Regola 144 e, se applicabile, della Regola 10b5-1.

Punti chiave:

  • Piccola vendita aggiuntiva da parte di un insider rispetto alle azioni in circolazione.
  • Trend continuo di cessione da parte di insider (circa lo 0,06% delle azioni in circolazione negli ultimi 90 giorni).
  • Vendita effettuata tramite broker consolidato; nessuna menzione di lock-up o restrizioni.

Ventas, Inc. (VTR) – Presentación del Formulario 144: Robert F. Probst ha presentado un aviso para vender 3,900 acciones comunes a través de Merrill Private Wealth alrededor del 31 de julio de 2025. Las acciones fueron adquiridas el mismo día mediante un ejercicio sin desembolso de opciones sobre acciones para empleados. El valor de mercado estimado agregado es de 266,960 $. Ventas reporta 454,471,192 acciones en circulación, por lo que la venta propuesta equivale aproximadamente al 0,0009% del flotante.

El declarante ya ha vendido 288,875 acciones comunes de Ventas durante los últimos tres meses en cinco transacciones, generando 18,86 millones de $ en ingresos brutos. No se afirma información adversa sobre el emisor en la presentación, y el declarante certifica el cumplimiento de la Regla 144 y, si corresponde, de la Regla 10b5-1.

Puntos clave:

  • Pequeña venta adicional de insider en relación con las acciones en circulación.
  • Tendencia continua de disposición por parte de insiders (≈0,06 % de las acciones en circulación en los últimos 90 días).
  • Venta realizada a través de un corredor establecido; sin menciones de bloqueos o restricciones.

Ventas, Inc. (VTR) – Form 144 신고: Robert F. Probst는 Merrill Private Wealth를 통해 2025년 7월 31일경 3,900 보통주를 매도할 예정임을 신고했습니다. 해당 주식은 같은 날 현금 지불 없는 직원 주식 옵션 행사를 통해 취득했습니다. 추정 총 시장 가치는 266,960달러입니다. Ventas는 454,471,192 주가 유통 중이라고 보고했으며, 제안된 매도는 유통 주식의 약 0.0009%에 해당합니다.

신고자는 지난 3개월 동안 다섯 건의 거래를 통해 이미 288,875 주를 매도하여 총 1886만 달러의 매출을 올렸습니다. 신고서에는 발행사에 대한 부정적인 정보가 없으며, 신고자는 Rule 144 및 해당되는 경우 Rule 10b5-1 준수를 인증합니다.

주요 내용:

  • 유통 주식 대비 소규모 추가 내부자 매도.
  • 지속적인 내부자 주식 처분 추세(최근 90일간 약 0.06%).
  • 기존 중개인을 통한 매도; 락업 또는 제한 사항 언급 없음.

Ventas, Inc. (VTR) – Dépôt du formulaire 144 : Robert F. Probst a déposé un avis de vente de 3 900 actions ordinaires via Merrill Private Wealth aux alentours du 31 juillet 2025. Les actions ont été obtenues le même jour par un exercice sans décaissement d'options d'achat d'actions pour employés. La valeur marchande totale estimée est de 266 960 $. Ventas rapporte 454 471 192 actions en circulation, donc la vente proposée représente environ 0,0009 % du flottant.

Le déclarant a déjà vendu 288 875 actions ordinaires de Ventas au cours des trois derniers mois lors de cinq transactions, générant 18,86 millions $ de produit brut. Aucune information défavorable sur l'émetteur n'est mentionnée dans le dépôt, et le déclarant certifie sa conformité à la règle 144 et, le cas échéant, à la règle 10b5-1.

Points clés :

  • Petite vente supplémentaire d'initié par rapport aux actions en circulation.
  • Tendance continue de cession d'initiés (≈0,06 % des actions en circulation au cours des 90 derniers jours).
  • Vente réalisée via un courtier établi ; aucune mention de clauses de blocage ou restrictions.

Ventas, Inc. (VTR) – Form 144 Einreichung: Robert F. Probst hat eine Mitteilung eingereicht, um etwa am 31. Juli 2025 3.900 Stammaktien über Merrill Private Wealth zu verkaufen. Die Aktien wurden am selben Tag durch eine barkostenneutrale Ausübung von Mitarbeiteraktienoptionen erworben. Der geschätzte Gesamtmarktwert beträgt 266.960 $. Ventas meldet 454.471.192 ausstehende Aktien, sodass der vorgeschlagene Verkauf etwa 0,0009 % des Streubesitzes entspricht.

Der Melder hat in den letzten drei Monaten bereits 288.875 Ventas-Stammaktien in fünf Transaktionen verkauft und dabei 18,86 Millionen $ Bruttoerlös erzielt. Im Formular werden keine negativen Informationen über den Emittenten angegeben, und der Melder bestätigt die Einhaltung von Regel 144 und gegebenenfalls Regel 10b5-1.

Wesentliche Erkenntnisse:

  • Kleine zusätzliche Insider-Verkauf im Verhältnis zu den ausstehenden Aktien.
  • Fortgesetzter Trend von Insider-Veräußerungen (≈0,06 % der ausstehenden Aktien in den letzten 90 Tagen).
  • Verkauf über etablierten Broker; keine Hinweise auf Sperrfristen oder Einschränkungen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine but continued insider selling; impact modest.

The proposed 3,900-share sale is immaterial to Ventas’ 454 M share count and appears linked to option exercise. However, cumulative insider disposals of 288,875 shares (~0.06 %) in the last quarter show an ongoing selling cadence that investors may monitor for sentiment. No operational data or guidance changes accompany the filing, so valuation impact is limited. Overall, neutral signal with a slight negative bias given the selling trend.

TL;DR: Filing demonstrates procedural compliance; selling trend bears watching.

The Form 144 contains full disclosure of share origin, broker, and Rule 10b5-1 representation, indicating sound adherence to SEC rules. Single-day option exercise followed by immediate sale is typical for liquidity or tax obligations. While governance risk is low, repetitive sales by the same insider may raise perception issues among shareholders. Monitoring future filings will clarify whether this is scheduled diversification or opportunistic selling.

Ventas, Inc. (VTR) – Comunicazione Form 144: Robert F. Probst ha presentato una notifica per la vendita di 3.900 azioni ordinarie tramite Merrill Private Wealth intorno al 31 luglio 2025. Le azioni sono state ottenute lo stesso giorno mediante un esercizio senza esborso di opzioni azionarie per dipendenti. Il valore di mercato aggregato stimato è di 266.960 $. Ventas riporta 454.471.192 azioni in circolazione, quindi la vendita proposta rappresenta circa lo 0,0009% del flottante.

Il dichiarante ha già venduto 288.875 azioni ordinarie di Ventas negli ultimi tre mesi in cinque transazioni, generando 18,86 milioni di $ di ricavi lordi. Nel modulo non sono riportate informazioni negative sull’emittente e il dichiarante certifica il rispetto della Regola 144 e, se applicabile, della Regola 10b5-1.

Punti chiave:

  • Piccola vendita aggiuntiva da parte di un insider rispetto alle azioni in circolazione.
  • Trend continuo di cessione da parte di insider (circa lo 0,06% delle azioni in circolazione negli ultimi 90 giorni).
  • Vendita effettuata tramite broker consolidato; nessuna menzione di lock-up o restrizioni.

Ventas, Inc. (VTR) – Presentación del Formulario 144: Robert F. Probst ha presentado un aviso para vender 3,900 acciones comunes a través de Merrill Private Wealth alrededor del 31 de julio de 2025. Las acciones fueron adquiridas el mismo día mediante un ejercicio sin desembolso de opciones sobre acciones para empleados. El valor de mercado estimado agregado es de 266,960 $. Ventas reporta 454,471,192 acciones en circulación, por lo que la venta propuesta equivale aproximadamente al 0,0009% del flotante.

El declarante ya ha vendido 288,875 acciones comunes de Ventas durante los últimos tres meses en cinco transacciones, generando 18,86 millones de $ en ingresos brutos. No se afirma información adversa sobre el emisor en la presentación, y el declarante certifica el cumplimiento de la Regla 144 y, si corresponde, de la Regla 10b5-1.

Puntos clave:

  • Pequeña venta adicional de insider en relación con las acciones en circulación.
  • Tendencia continua de disposición por parte de insiders (≈0,06 % de las acciones en circulación en los últimos 90 días).
  • Venta realizada a través de un corredor establecido; sin menciones de bloqueos o restricciones.

Ventas, Inc. (VTR) – Form 144 신고: Robert F. Probst는 Merrill Private Wealth를 통해 2025년 7월 31일경 3,900 보통주를 매도할 예정임을 신고했습니다. 해당 주식은 같은 날 현금 지불 없는 직원 주식 옵션 행사를 통해 취득했습니다. 추정 총 시장 가치는 266,960달러입니다. Ventas는 454,471,192 주가 유통 중이라고 보고했으며, 제안된 매도는 유통 주식의 약 0.0009%에 해당합니다.

신고자는 지난 3개월 동안 다섯 건의 거래를 통해 이미 288,875 주를 매도하여 총 1886만 달러의 매출을 올렸습니다. 신고서에는 발행사에 대한 부정적인 정보가 없으며, 신고자는 Rule 144 및 해당되는 경우 Rule 10b5-1 준수를 인증합니다.

주요 내용:

  • 유통 주식 대비 소규모 추가 내부자 매도.
  • 지속적인 내부자 주식 처분 추세(최근 90일간 약 0.06%).
  • 기존 중개인을 통한 매도; 락업 또는 제한 사항 언급 없음.

Ventas, Inc. (VTR) – Dépôt du formulaire 144 : Robert F. Probst a déposé un avis de vente de 3 900 actions ordinaires via Merrill Private Wealth aux alentours du 31 juillet 2025. Les actions ont été obtenues le même jour par un exercice sans décaissement d'options d'achat d'actions pour employés. La valeur marchande totale estimée est de 266 960 $. Ventas rapporte 454 471 192 actions en circulation, donc la vente proposée représente environ 0,0009 % du flottant.

Le déclarant a déjà vendu 288 875 actions ordinaires de Ventas au cours des trois derniers mois lors de cinq transactions, générant 18,86 millions $ de produit brut. Aucune information défavorable sur l'émetteur n'est mentionnée dans le dépôt, et le déclarant certifie sa conformité à la règle 144 et, le cas échéant, à la règle 10b5-1.

Points clés :

  • Petite vente supplémentaire d'initié par rapport aux actions en circulation.
  • Tendance continue de cession d'initiés (≈0,06 % des actions en circulation au cours des 90 derniers jours).
  • Vente réalisée via un courtier établi ; aucune mention de clauses de blocage ou restrictions.

Ventas, Inc. (VTR) – Form 144 Einreichung: Robert F. Probst hat eine Mitteilung eingereicht, um etwa am 31. Juli 2025 3.900 Stammaktien über Merrill Private Wealth zu verkaufen. Die Aktien wurden am selben Tag durch eine barkostenneutrale Ausübung von Mitarbeiteraktienoptionen erworben. Der geschätzte Gesamtmarktwert beträgt 266.960 $. Ventas meldet 454.471.192 ausstehende Aktien, sodass der vorgeschlagene Verkauf etwa 0,0009 % des Streubesitzes entspricht.

Der Melder hat in den letzten drei Monaten bereits 288.875 Ventas-Stammaktien in fünf Transaktionen verkauft und dabei 18,86 Millionen $ Bruttoerlös erzielt. Im Formular werden keine negativen Informationen über den Emittenten angegeben, und der Melder bestätigt die Einhaltung von Regel 144 und gegebenenfalls Regel 10b5-1.

Wesentliche Erkenntnisse:

  • Kleine zusätzliche Insider-Verkauf im Verhältnis zu den ausstehenden Aktien.
  • Fortgesetzter Trend von Insider-Veräußerungen (≈0,06 % der ausstehenden Aktien in den letzten 90 Tagen).
  • Verkauf über etablierten Broker; keine Hinweise auf Sperrfristen oder Einschränkungen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gendel Mitchell

(Last) (First) (Middle)
C/O TILRAY BRANDS, INC.
265 TALBOT STREET WEST

(Street)
LEAMINGTON A6 N8H 4H3

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Tilray Brands, Inc. [ TLRY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Global General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/30/2025 M 243,781(1) A $0.61 777,345(2) D
Common Stock 07/30/2025 F 129,204(3) D $0.61 648,141(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (4) 07/30/2025 M 243,781 (4) (4) Common Stock 243,781 $0 243,781 D
Restricted Stock Units (5) 07/29/2025 A 1,748,793 (6) (6) Common Stock 1,748,793 $0 1,748,793 D
Explanation of Responses:
1. On July 30, 2024, the reporting person was granted 487,562 of 2024 RSUs, and 243,781 RSUs vested on July 30, 2025.
2. Amount includes shares of Common Stock beneficially owned by the reporting person but excludes other unvested RSUs.
3. Represents shares withheld by the Company to satisfy the tax withholding obligation associated with the vesting of 243,781 2024 RSUs previously granted on July 30, 2024.
4. Each unit represents a contingent right to receive one (1) share of Tilray Common Stock.
5. Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Common Stock. Grant date is based on close of trading on July 29, 2025.
6. Subject to the reporting person's continuous employment through the vesting date, the LTIP RSUs shall vest in two (2) equal annual installments, commencing on July 29, 2026, and July 29, 2027, except in the case of the reporting person's earlier voluntary resignation, death or disability. In the event of a voluntary termination by the reporting person prior to the vesting date, all RSUs will be forfeited.
/s/ Mitchell Gendel 07/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
TILRAY BRANDS INC

NASDAQ:TLRY

TLRY Rankings

TLRY Latest News

TLRY Latest SEC Filings

TLRY Stock Data

672.74M
1.05B
0.77%
9.06%
16.94%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
NEW YORK